Navigation Links
Many prostate cancer patients receive improper or 'mismatched' therapies
Date:11/25/2007

Prostate cancer patients often receive treatment that is contraindicated by pre-existing conditions, like urinary or bowel dysfunction, according to a new study. Dr. James Talcott of the Massachusetts General Hospital in Boston and co-investigators found that patients with certain pretreatment dysfunctions often receive contraindicated or mismatched therapies, which can lead to worse outcomes. The study is published in the January 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

The American Cancer Society estimates that more than 218,000 American men are diagnosed with prostate cancer and more than 27,000 die from the disease each year. The three most common treatments for the disease are external beam radiation, brachytherapy, and radical prostatectomy.

Clinical studies have found no differences in efficacy among the three major therapies for the treatment of prostate cancer, but each brings with it certain risks, such as urinary incontinence or sexual dysfunction. Therefore, the best therapy for a particular patient will depend on the individuals pre-treatment status. For example, patients with pre-existing bowel dysfunction should not receive external beam radiation as a first line of therapy because the treatment inevitably irradiates the adjacent rectum in addition to the prostate and causes acute and long-term bowel dysfunction. Similarly, patients with problematic urinary obstructive symptoms should not receive brachytherapy, which delivers radiation to the prostate and can cause complete obstruction in patients with pre-existing obstructive symptoms.

Dr. Talcott and his colleagues surveyed 438 patients who sought therapy for untreated, localized prostate cancer from several hospitals in the Boston area between June 1, 1994 and August 31, 2000. Several additional questionnaires were mailed to patients until 36 months after treatment, and medical records were reviewed.

The study shows t
'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Red wine compound shown to prevent prostate cancer
7. Barbershop Talks Cut Black Mens Prostate Cancer Risk
8. Generic prostate drug helps find high-risk cancers early
9. Finasteride unlikely to induce high grade prostate cancers
10. Shrinkage of prostate led to overestimation of cancer risk in trial
11. Prostate Cancer Awareness Week to Screen Thousands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...A cleanroom manufacturing company has introduced a...he feature is a utility panel which can be integra...nroom appearance. , Burns...eering, a designer, fabricator and installer of cl... offering a utility panel for integration into its...
(Date:7/24/2008)...swire-FirstCall/ --, Key Highlights, Misys plc (...nd is now,raising targets for the next phase of th... GBP492m up 6%, bringing Group operating profit(2)...ting on its strategy and entering,into the next ph...r growth., To view the Multimedia News Release, p...
(Date:7/23/2008)...d for better physician-administration relations ...sicians, SOUTH BEND, Ind., July 24 /PRNewswire/ -...eport: Physician Perspectives on American Hospital...ysician-administration,relationship, and physician...onsive to the ideas and needs of medical staff. Th...
(Date:7/23/2008)... welcome to out-of-state intended parents, SAN RA...lifornia,Supreme Court decision to allow gay coupl...oductive Science Center of the Bay Area (RSC), one...rving gays and lesbians for,infertility treatment.... supports RSC,s,long-held views that procreation i...
Breaking Medicine News(10 mins):Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:Authoritative Report on Physician Perspectives Released Today 2Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2
...Leire Garca Navarro, a researcher at the School of... hopes for patients suffering colon and liver canc...ing the growth of such cancers. This discovery i...ral dissertation, entitled Lipo-Polymeric Vectors ...
...bouts of nausea and vomiting during their pregnanc...it but it seems that going through morning sicknes...o have conducted a new study and found that women ...ve a 30 percent lower risk of developing breast ca...
...oking rate has shown a decline, thanks to the comp...kick the habit. The statistics in the 2006 report...mparison to 2002 figures. Over the past year, smok... to 19.9%) and among Hispanics (from 20.2% to 17.1...
...r on switch triggers gene activity that cause eff... to glucose production in the liver was discovere...spital . The on switch, a protein called CREB, is...binds to a section of DNA near a gene and triggers...
Other Medicine News:Health News:Novel Treatment Beneficial for Colon and Liver Cancer 2Health News:Morning Sickness may Signify Lower Breast Cancer Risk 2Health News:Morning Sickness may Signify Lower Breast Cancer Risk 3Health News:New York Records Decline in Smoking Rate 2Health News:Research Studies on Molecular Switches of Gene 2
(Date:7/22/2008)...Regimens Including Lantus(R) and Apidra(R) Resulte...th Type 2 Diabetes, Whatever the Algorithm ..., July 22 /- Results from the "Adjust...ple Algorithm to Carbohydrate,Counting for Adjustm...lished in the American Diabetes Association,s (ADA...
(Date:7/22/2008)...veloped and Validated by Columbia University Medic...prietary MicroRNA Technology, The Test Different...ng Cancer (NSCLC), Classifying Squamous-Cell Carc...rcent and Specificity of 90 Percent,This is the Fi...Sensitivity as Biomarkers for Accurate Di...
(Date:7/22/2008)...ot Study Suggests That Ekkyo,s New Approach of LAS...y Improve Scar Healing Physiology, MARSEILLES, Fr...n as,Heatwave Technology) a photomedicine company,... for skin scar prevention and reduction, announced...Lasers in Surgery and Medicine*,reporting the resu...
(Date:7/21/2008)...DON, July 21 /- The SEAS (Simvastatin...tigated the effects of intensive,cholesterol lower...ly) and,ezetimibe (10 mg daily) in patients with a...partial blockage of the aortic valve in,the heart)... in Western,populations. Left untreated, it can pr...
Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4Liver transplant offers survival benefits for patients of all sizes 7546 1Liver transplant offers survival benefits for patients of all sizes 7546 2Liver transplant offers survival benefits for patients of all sizes 7546 32 in 1 Test Signals Risk After Heart Attack 7543 12 in 1 Test Signals Risk After Heart Attack 7543 22 in 1 Test Signals Risk After Heart Attack 7543 3HealthCentral coms New Stop Smoking Site Provides Expert Advice Supportive Community to Help Smokers Quit 7539 1HealthCentral coms New Stop Smoking Site Provides Expert Advice Supportive Community to Help Smokers Quit 7539 2Dietitians Urge Parents to Serve Milk With Meals 7535 1Dietitians Urge Parents to Serve Milk With Meals 7535 2Dietitians Urge Parents to Serve Milk With Meals 7535 3
...ard/Conventional Blade. Stainless Steel. Lamp supp... of high quality standard incandescent laryngoscop...ntinually refined through many years of use the wo...y are manufactured to exacting specifications from...
... Snap-Light™ laryngoscope blades are designe...iber optic bundle can be removed to simplify clean...ue snap-on mechanism eliminates screws that can be...ngeable with other green coded fiber optic systems...
...spec Laryngoscopes are a high quality fiberoptic s...r standardization to fiberoptic laryngoscopes. The...d indicates it's ability to interconnect with othe...t offers a cool, bright and focused light. The Gre...
...spec Laryngoscopes are a high quality fiberoptic s...r standardization to fiberoptic laryngoscopes. The...d indicates it's ability to interconnect with othe...t offers a cool, bright and focused light. The Gre...
Medicine Products: